CHTH · As filed with the SEC
CNL Healthcare Properties income statement, by quarter
The statement as CNL Healthcare Properties presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) · USD thousands, except per-share amounts; shares in thousands
| USD thousands, except per-share amounts; shares in thousands | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 |
|---|---|---|---|---|
| Revenues: | ||||
| Rental income and related revenues | 7,551 | 7,002 | 6,834 | 6,759† |
| Resident fees and services | 91,743 | 90,362 | 88,805 | 86,439† |
| Total revenues | 99,294 | 97,364 | 95,639 | 93,198† |
| Operating expenses: | ||||
| Property operating expenses | 66,439 | 64,488 | 64,259 | 63,765† |
| General and administrative expenses | 2,537 | 2,181 | 2,336 | 2,508† |
| Asset management fees | 3,452 | 3,452 | 3,489 | 3,342† |
| Property management fees | 4,537 | 4,496 | 4,377 | 4,283† |
| Financing coordination fees | — | — | — | 0† |
| Depreciation and amortization | 12,901 | 13,197 | 12,712 | 12,904† |
| Total operating expenses | 89,866 | 87,814 | 87,173 | 86,802† |
| Operating income | 9,428 | 9,550 | 8,466 | 6,396† |
| Other income (expense): | ||||
| Interest and other income | 113 | 150 | 113 | 196† |
| Interest expense and loan cost amortization | (10,938) | (11,038) | (10,985) | (11,294)† |
| Total other expense | (10,825) | (10,888) | (10,872) | (11,098)† |
| Loss before income taxes | (1,397) | (1,338) | (2,406) | (4,702)† |
| Income tax expense | (181) | (154) | (162) | (248)† |
| Net loss | (1,578) | (1,492) | (2,568) | (4,950)† |
| Less: Amounts attributable to noncontrolling interests | 0 | 0 | 0 | 1† |
| Net loss attributable to common stockholders | (1,578) | (1,492) | (2,568) | (4,951)† |
| Net loss per share of common stock, basic (in dollars per share) | (0.01) | (0.01) | (0.01) | — |
| Net loss per share of common stock, diluted (in dollars per share) | (0.01) | (0.01) | (0.01) | — |
| Weighted average number of shares of common stock outstanding, basic (in shares) | 173,942 | 173,942 | 173,942 | — |
| Weighted average number of shares of common stock outstanding, diluted (in shares) | 173,942 | 173,942 | 173,942 | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.